老年人多重用药及评价工具的研究进展  

Progress on polypharmacy and evaluation tools for prescriptions in the elderly

作　　者：李莹[1] 钱玉英[1] 李耘[1] 马丽娜[1] LI Ying;QIAN Yu-Ying;LI Yun;MA Li-Na(Department of Geriatrics,Capital Medical University,National Research Center for Geriatric Medicine,Xuanwu Hospital,Beijing 100053,China)

机构地区：[1]首都医科大学宣武医院老年医学科,国家老年疾病临床医学研究中心,北京100053

出　　处：《中华老年多器官疾病杂志》2021年第3期229-232,共4页Chinese Journal of Multiple Organ Diseases in the Elderly

基　　金：国家重点研发计划(2018YFC2002101,2018YFC2002100,2017YFBl401202);北京市属医院科研培育计划项目(PX2020036)。

摘　　要：我国老龄化问题日益严峻,这对老年人相关疾病的诊治提出了新的挑战。老年综合评估是老年医学的核心技术,是对老年患者的躯体功能、精神心理、社会环境、生活质量及多重用药等多方面进行的全面个体化评估。其中多重用药是老年人中一种常见的老年综合征,会增加老年人药物不良反应的发生风险,对老年人多重用药采取行之有效的评估和干预已成为亟待解决的问题。因此,本文将对老年人多重用药的现状和老年人用药评价工具的研究进展作一综述。Aging problem is becoming more and more serious,which has brought new challenges to the diagnosis and treatment of diseases for the elderly.Comprehensive geriatric assessment is the core technology in geriatric researches,and it is to make a comprehensive individualized evaluation of physical functions,mental psychology,social environment,quality of life,polypharmacy and other aspects in the elderly patients.However,polypharmacy is one of the common conditions for the aged,and it increases the risk of adverse drug reactions.Therefore,effective evaluation and intervention of polypharmacy for the elderly has become an urgent issue.In this review,we evaluate the current status of polypharmacy in the elderly and the research progress on evaluation tools for prescriptions in elderly individuals.

关 键 词：老年人 多重用药 老年综合评估 

分 类 号：R969.3[医药卫生—药理学]